Onegene Biotechnology

About:

Onegene Biotechnology develops highly potent tri- or intraspecific protein-based drugs.

Top Investors: TIPS Program, UTC Investment Co., KB Securities, Stonebridge Ventures, Korea Omega Investment

Description:

Onegene Biotechnology is a biotechnology company that develops highly potent tri- or intraspecific protein-based drugs. It allows an unlimited combination of different types of molecules, such as Fab fragment, scFv, sdAb, peptide, cytokines, agonist/antagonist, or enzymes. The unprecedented design flexibility with optimized physical properties opens new design space for multispecific protein drugs with CMC feasibility.

Total Funding Amount:

$12.7M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Seongnam, Kyonggi-do, South Korea

Founded Date:

2016-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2022-05-01

IPO Status:

Private

Industries: